Savior of Divine Blood
Scope
Date
~
-
Bio & Pharma
JW Pharma applies for phase 3 trial in Taiwan for gout treatment
JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's GI Cell, Japanese partner to study cell therapy for blood cancer
South Korea's GI Cell, the cell therapy affiliate of GI Innovation, on Tuesday said it signed an agreement with Optieum Biotechnologies of Japan on ...
Dec 14, 2022 (Gmt+09:00)
-
Korean food
Want to improve memory? Eat more ginseng
Consumption of ginseng and red ginseng (hongsam) can improve memory capacity and prevent high blood pressure, diabetes and muscle loss, according to...
Nov 02, 2022 (Gmt+09:00)
-
Foreign exchange
NPS emerges as savior of Korea’s ailing won currency
The South Korean state-run National Pension Service (NPS) has been spotted selling dollars for won, supporting the ailing local unit, as the world&r...
Oct 20, 2022 (Gmt+09:00)
-
Perspectives
Yen’s plunge raising blood pressures in Asia
Episodes of extreme yen weakness don’t tend to go well for Asia. In the late 1990s, early 2010s and today, a sliding yen often proves to be even...
Jul 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis’ SB12 shows same clinical effects as Alexion’s Soliris
Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, said its SB12, a proposed biosimilar to Alexion Pharmaceuticals Inc.’s rare bl...
Jun 14, 2022 (Gmt+09:00)
language -
Bio & Pharma
FDA to review Hanmi Pharmaceutical’s Rolontis for marketing approval
The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...
Apr 13, 2022 (Gmt+09:00)
-
Healthcare
InBody to expand into household, blood pressure monitoring markets
South Korea’s InBody Co., the global market leader of body composition analyzer devices, will be making a strategic turn to focus on the fast-...
Oct 06, 2021 (Gmt+09:00)
-
Biotech
IMB Dx eyes platform to detect stage 1 cancer with single draw of blood
IMB Dx Inc., a South Korean biotechnology startup focusing on diagnostic devices, plans to develop a platform that can detect early-stage cancer wit...
Jul 22, 2021 (Gmt+09:00)
Latest News
- 1 Maybe Happy Ending: How a Seoul-made robot love story rewrote Broadway playbook
- 2 NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen
- 3 Woori Financial wins approval for Tongyang, ABL Life acquisition
- 4 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 5 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs